Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Dec 12, 2016 at 10:35 AM EST

Achaogen Rises on Late-Stage Win

Achaogen shares saw a huge gain on Monday after the company reported positive results from a late-stage trial of its…

Chris Lange | Dec 12, 2016 at 9:10 AM EST

Biotech Short Interest Remains Mixed

The November 30 short interest data have been compared with the previous report, and short interest was mixed in the…

Chris Lange | Dec 12, 2016 at 8:44 AM EST

Short Sellers Back Way Off Major Pharma Stocks

The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected…

Lee Jackson | Dec 12, 2016 at 8:20 AM EST

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political…

Chris Lange | Dec 9, 2016 at 10:15 AM EST

Clearside Biomedical Closes in on Secondary Offering

Clearside Biomedical now expects to price its 4 million shares at $9.00 per share for a secondary offering valued up…

Paul Ausick | Dec 9, 2016 at 7:35 AM EST

Express Scripts Thumped by Short Seller Citron Research

Around noon on Thursday, short-seller Citron Research offered some free advice to President-Elect Donald Trump: If Trump is serious about…

Chris Lange | Dec 8, 2016 at 2:55 PM EST

Ohr Pharma Drops on Secondary Offering

Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) is watching its shares drop on Thursday after the company announced the pricing of a…

Chris Lange | Dec 8, 2016 at 12:50 PM EST

Jaguar Animal Health Gears Up for Secondary Offering

Jaguar Animal Health has filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering of more than…

Chris Lange | Dec 8, 2016 at 12:20 PM EST

Endo Sells Back Its Rights to Opioid Drug and Moves to Restructure

Shares of Endo International saw a handy gain on Thursday after the company announced that it sold back its rights…

Chris Lange | Dec 8, 2016 at 11:50 AM EST

Recro Pharma Secondary Offering (UPDATE)

Recro Pharma intends to offer more than 5 million shares at $6.99 apiece in a secondary offering valued at roughly…

Chris Lange | Dec 8, 2016 at 10:25 AM EST

Horizon Pharma Falls on Late-Stage Miss and Discontinuation

Horizon Pharma PLC saw its shares take a big step back on Thursday after the company reported topline results from…

Jon C. Ogg | Dec 7, 2016 at 12:40 PM EST

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Trump told Time that he wants to lower drug prices, a move that has hit the drug and biotech segments…

Chris Lange | Dec 7, 2016 at 12:05 PM EST

Repros Therapeutics Drops on FDA Vote

Repros Therapeutics saw its shares take a loss on Wednesday after the company provided a key FDA update.

Chris Lange | Dec 6, 2016 at 10:50 AM EST

Teva Shares Slide on Management Change

Teva Pharmaceutical Industries shares sank on Tuesday after the company announced the appointment of Dipankar Bhattacharjee as chief executive for…

Chris Lange | Dec 5, 2016 at 1:05 PM EST

10 Major Pharma and FDA Catalysts Coming in December

24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.

1 … 181 182 183 184 185 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Achaogen Rises on Late-Stage Win

Biotech Short Interest Remains Mixed

Short Sellers Back Way Off Major Pharma Stocks

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

Clearside Biomedical Closes in on Secondary Offering

Express Scripts Thumped by Short Seller Citron Research

Ohr Pharma Drops on Secondary Offering

Jaguar Animal Health Gears Up for Secondary Offering

Endo Sells Back Its Rights to Opioid Drug and Moves to Restructure

Recro Pharma Secondary Offering (UPDATE)

Horizon Pharma Falls on Late-Stage Miss and Discontinuation

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Repros Therapeutics Drops on FDA Vote

Teva Shares Slide on Management Change

10 Major Pharma and FDA Catalysts Coming in December

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Achaogen Rises on Late-Stage Win

Biotech Short Interest Remains Mixed

Short Sellers Back Way Off Major Pharma Stocks

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

Clearside Biomedical Closes in on Secondary Offering

Express Scripts Thumped by Short Seller Citron Research

Ohr Pharma Drops on Secondary Offering

Jaguar Animal Health Gears Up for Secondary Offering

Endo Sells Back Its Rights to Opioid Drug and Moves to Restructure

Recro Pharma Secondary Offering (UPDATE)

Horizon Pharma Falls on Late-Stage Miss and Discontinuation

Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares

Repros Therapeutics Drops on FDA Vote

Teva Shares Slide on Management Change

10 Major Pharma and FDA Catalysts Coming in December

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check